Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-04-027264

Chief Scientific Officer bought 2,000 shares at an average $7.46 ($14,912)

From the SEC's structured data for this filing

Trades in this filing

CHAPLIN DAVID · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2004-05-21 Purchase : show line 1 in the form +200 $7.47 $1,494 200 I
2004-05-21 Purchase : show line 2 in the form +1,500 $7.46 $11,190 1,700 I
2004-05-21 Purchase : show line 3 in the form +200 $7.45 $1,490 1,900 I
2004-05-21 Purchase : show line 4 in the form +100 $7.38 $738 2,000 I
Open-market purchases · 2,000 sh · avg $7.46 · $14,912
Loading xslF345X02/rrd43334.xml…